Kayla Sheehan

2PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|May 21, 2026
First Do No Harm: Communication Surrounding Non-Beneficial Treatments.

|Feb 28, 2019
Transcription factor Sp4 is required for hyperalgesic state persistence.

Kayla Sheehan, Jessica Lee, Jillian Chong

Pageof 1